View Older Stories View More Recent Stories

Jul 25, 2016 07:00AM Citius Pharmaceuticals Addresses Problem That Affects 10 Million People in the U.S.: Hemorrhoids

Jul 18, 2016 07:00AM Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok™ Phase 3 Trials

Jul 1, 2016 05:00PM Citius Pharmaceuticals Discontinues Suprenza™ To Focus on Core Assets

Jun 28, 2016 07:00AM Citius Pharmaceuticals, Inc. Announces Appointment of Dr. Eugene Holuka to Its Board of Directors

May 12, 2016 07:00AM Citius Announces Completion of Private Placement Financing

Apr 4, 2016 07:00AM Citius Pharmaceuticals Completes Acquisition of Leonard-Meron Biosciences

Mar 23, 2016 07:00AM Citius Pharmaceuticals Announces Significant Equity Investment from Chairman and CEO

Mar 7, 2016 07:00AM Citius Pharmaceuticals Signs Letter of Intent to Acquire Leonard Meron Biosciences

Feb 1, 2016 07:00AM Citius Pharmaceuticals Announces Results from Phase 2a Trial of Hydrocortisone and Lidocaine Combination Cream in Patients with Grade I and II Hemorrhoids

Oct 8, 2015 07:00AM Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors

Oct 6, 2015 07:00AM Citius Pharmaceuticals Announces Myron Holubiak, Former President of Roche Laboratories, Inc., USA, has Joined Its Board of Directors

View More Recent Stories View Older Stories